Relationships between antropyloroduodenal motility, gut hormone release, appetite and energy intake responses, and oral taste sensitivity, to fat and protein in male subjects with a range of body mass index (BMI).

Dr Natalie Luscombe-Marsh0 个研究点目标入组 60 人开始时间: 2012年9月4日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Significant gastrointestinal symptoms, disease, or surgery
•Use of prescribed or non-prescribed medications (including vitamins and herbal supplements) which may effect energy metabolism, gastrointestinal function, body weight, or appetite (eg. domperidone and cisapride, anticholinergic drugs (eg. atropine), metoclopramide, erythromycin, hyoscine, orlistat, green tea extracts, astragalus, St. johns wort etc.)
•Lactose intolerant or other food allergies (particularly MSG); intolerance or allergy to paracetamol
•Current, recurring or chronic rhinitis
•Current gallbladder or pancreatic disease; diabetes mellitus; epilepsy; cardiovascular or respiratory diseases; any other illnesses as assessed by the investigator (including chronic illnesses not explicitly listed above)
•Individuals with low ferritin levels or who have donated blood in the 12 weeks prior to taking part in the study
•Individuals with blood glucose and/or glycated haemoglobin outside the normal ranges.
•High performance athletes
•Current intake of >2 standard drinks on >5 days per week
•Current smokers of cigarettes/cigars/marijuana
•Current intake of any illicit substance
•Experience claustrophobia in confined spaces
•Unable to tolerate nasogastrointestinal tube, or to comprehend study protocol

发起方

Dr Natalie Luscombe-Marsh